The use of stem cells may open a new era in the management of multiple sclerosis (MS) and other neurodegenerative and neuroimmunological disorders. In the case of MS, the potential of stem cells ...

Neuraxpharm Ireland, part of Neuraxpharm Group, a leading European speciality pharmaceutical company focused on the treatment ...

The onset of multiple sclerosis (MS) in older individuals correlates with a higher risk of developing primary progressive MS, faster progression to secondary progressive MS, and increased disability ...

July 4, 2024 — Researchers have discovered several rare types of helper T cells that are associated with immune disorders such as multiple sclerosis, rheumatoid arthritis, and even asthma.

"With the global stem cell market expanding, we see an opportunity to make these treatments more accessible in the U.S.," ...

The next big advance in treating diseases like rheumatoid arthritis could be tiny pulses of electricity delivered to the ...

Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS). The immune system inflames the myelin that encases the nerve fibers, the cells that make the myelin, and the nerve ...

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell treatments to desperate patients looking for cures of intractable diseases and ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

Nearly 60,000 people are diagnosed with oral cancer in the U.S. every year, according to the American Cancer Society, and the ...